Aonjittra Phanrungsuwan

Dr. Aonjittra Phanrungsuwan

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2024 in Journal of Periodontology
Verified
Journal Article
Open access
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
MCMichael B. Chavez
Michael B. Chavez
LELeena A. Eltilib
Leena A. Eltilib
TKTamara N. Kolli
Tamara N. Kolli
FMFatma F. Mohamed
Fatma F. Mohamed
BFBrian Foster
Brian Foster
Background: Cellular cementum (CC) includes cementocytes, cells suspected to regulate CC formation or resorption as osteocytes do in bone. Sclerostin (SOST) is a secreted negative regulator of Wnt/β‐catenin signaling expressed by osteocytes and cementocytes. Osteocyte SOST expression reduces bone formation. We investigated the functional importance of SOST in CC compared with alveolar bone (AB) using a Sost knockout (Sost−/−) mouse model to better understand the role of cementocytes in CC.Methods: Mandibles and femurs of Sost−/− and wild‐type (WT) mice were analyzed at 42 and 120 days postnatal (dpn). Maxillary first molars were bilaterally extracted at 42 dpn and both AB healing (maxillary molar sockets) and CC apposition (mandibular first molars) were examined at 21 days post‐procedure. Analyses included micro‐computed tomography, histology, and immunohistochemistry.Results: Femur cortical and trabecular bone and mandibular bone volumes were similarly increased in Sost−/− versus WT mice at 42 and/or 120 dpn. In contrast to previous reports, CC was not increased by Sost−/− at either age. We conducted challenge experiments on AB and CC to explore tissue‐specific responses. Post‐extraction AB healing was improved by Sost deletion. In contrast, experimentally‐induced apposition in molars failed to stimulate increased CC formation in Sost−/− versus WT mice. Wnt pathway markers AXIN2 and DKK1, which were increased in Sost−/− versus WT AB osteocytes, were unchanged in cementocytes.Conclusions: These data indicate CC is less responsive than AB to SOST deletion. Within the study limitations, these results do not support cementocytes as critical for directing increased CC formation.Plain Language Summary: Sclerostin is a protein known to inhibit bone formation, and removing sclerostin leads to more bone formation. Cementum is the thin layer that covers the surface of the tooth's root. Previous studies suggest that inhibiting sclerostin can similarly increase the amount of cementum. We wanted to compare the response of cementum and bone when sclerostin is absent to understand similarities and differences between these two tissues. In this study, we removed the Sost gene (the gene which produces sclerostin) in mice. We found that mice without sclerostin have more bone in their legs and jaws. Moreover, mice without sclerostin also healed better after tooth removal compared with normal mice. Surprisingly, unlike previous studies, we found that the amount of cementum was not different in mice without sclerostin compared with normal mice. Additionally, we challenged the cementum by taking out the opposing tooth to cause the first mandibular molar to move up by building more cementum. Even with this challenge, we found no difference in the amount of cementum in mice lacking sclerostin compared with normal mice. Therefore, we conclude here that cementum is less sensitive to the absence of sclerostin compared with bone.

19 May 2025 in Bone
Verified
Journal Article
Open access
FMF.F. Mohamed
F.F. Mohamed
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
FOF. Amadeu de Oliveira
F. Amadeu de Oliveira
JMJ.L. Millán
J.L. Millán
BFBrian Foster
Brian Foster
Hypophosphatasia (HPP) is an inherited error-of-metabolism caused by loss-of-function mutations in ALPL-encoded tissue-nonspecific alkaline phosphatase (TNAP). HPP has wide-ranging severity, including a clinical subtype called odontohypophosphatasia (odonto HPP), which selectively affects craniofacial structures. Dentoalveolar defects in HPP can affect enamel, dentin, and alveolar bone, and deficient acellular cementum contributes to tooth loss. Global Alpl knockout phenocopies effects of severe HPP, but early lethality precludes longer-term studies. Aiming to create a mouse model replicating dentoalveolar effects of HPP, we used Wnt1Cre2 mice to conditionally delete Alpl in ectomesenchymal cells that make dentin, cementum, periodontal ligament (PDL), and alveolar bone. We compared appendicular and craniofacial skeletal effects of Wnt1Cre2 to Prx1Cre conditional Alpl ablation in limb bud mesenchyme. We also tested alveolar bone socket healing in Wnt1Cre2; Alplfl/fl conditional knockout mice and the effect of TNAP-Fc-D10 enzyme replacement therapy (ERT) on socket healing. Prx1Cre; Alplfl/fl mice exhibited 38 % reduced circulating alkaline phosphatase (ALP) and long bone defects, but no craniofacial phenotypes. Wnt1Cre2; Alplfl/fl mice featured 60 % reduced ALP and profound mineralization defects in dentin, cementum, and alveolar bone, but no appendicular skeleton changes. Defects were noted in neural crest-derived intersphenoid synchondrosis of the cranial base and mandibular condyle of Wnt1Cre2; Alplfl/fl mice. Extraction of maxillary molars in Wnt1Cre2; Alplfl/fl mice revealed profound alveolar bone healing defects that were partially rescued by ERT. Cranial neural crest deletion of Alpl resulted in a mouse model phenocopying odonto HPP that can be used to investigate mechanisms underlying pathologies as well as interventions.

8 October 2025 in Journal of Periodontal Research
Verified
Journal Article
Open access
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
BDBella Donnelly
Bella Donnelly
JMJose Luis Millan
Jose Luis Millan
BFBrian Foster
Brian Foster
Aim: X‐linked Hypophosphatemia (XLH), caused by PHEX mutations, hinders skeletal and dental mineralization and contributes to tooth loss. While XLH is associated with dental implant‐related complications, no clinical or preclinical studies have investigated socket healing. XLH secondarily disrupts local mineral metabolism by increasing levels of the mineralization inhibitors, osteopontin (OPN) and inorganic pyrophosphate (PP i ). Tissue‐nonspecific alkaline phosphatase (TNAP) promotes mineralization by dephosphorylating OPN and hydrolyzing PP i . In this proof‐of‐principle study, we hypothesized that alveolar bone socket healing defects in the Hyp mouse model of XLH would be improved by exogenous TNAP. Methods: Maxillary first molars were extracted from wild‐type (WT) and Hyp mice at 6 weeks, and collagen gel ± mineral‐targeted TNAP (TNAP‐Fc‐D 10 ; asfotase alfa) was placed in sockets. Submucosal injections of TNAP‐Fc‐D 10 or saline were delivered at 7 and 14 days post‐procedure (dpp) in some mice. Maxillae were collected at 21 dpp for micro‐computed tomography, histology, and RT‐qPCR. Results: Untreated Hyp mice showed impaired socket healing compared to WT mice in bone volume and density. TNAP delivered at the time of extraction was unable to improve healing in Hyp mice. However, additional local TNAP delivery increased both alveolar bone volume and density in Hyp mice. Histology indicated repeated TNAP increased both woven and mature bone in Hyp mouse sockets. Immunostaining for osteopontin and bone sialoprotein suggested partial resolution of osteoid accumulation. Conclusion: TNAP enhanced socket healing in Hyp mice, overcoming inherent bone healing defects in XLH. These results provide new insights into bone healing with implications beyond alveolar bone in XLH.

1 October 2025 in Applied Sciences
Verified
Journal Article
Open access
PDF file
FFFatma Fenesha
Fatma Fenesha
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
BFBrian Foster
Brian Foster
ADAnibal Diogenes
Anibal Diogenes
Sarah B PetersSarah B Peters
Sarah B Peters
Introduction: Direct pulp capping (DPC) aims to preserve the vitality of the dental pulp by placing a protective biocompatible material over the exposed pulp tissue to facilitate healing. There are several calcium-silicate materials that have been designed to promote mineralization and the regulation of inflammation. These have strong potential for the repair and regeneration of dental pulp. Among them, Biodentine (BD) and EndoSequence RRM Putty (ES) have been found to promote in vitro and in vivo mineralization while minimizing some of the limitations of the first-generation calcium-silicate-based materials. Theracal-LC (TLC), a light-cured, resin-modified calcium-silicate material, is a newer product with potential to improve the clinical outcomes of DPC, but existing studies have reported conflicting findings regarding its biocompatibility and ability to support pulpal healing in direct contact with the pulp. A comprehensive assessment of the biocompatibility and pulpal protection provided by these three capping materials has not yet been performed. Aim: We aimed to quantify the inflammatory response, dentin bridge formation, and material adaptation following DPC using three calcium-silicate materials: ES, BD, and TLC. Materials and Methods: DPC was performed on the maxillary first molar of C57BL/6 female mice. Maxilla were collected and processed at 1 and 21 days post-DPC. The early inflammatory response was measured 24 h post-procedure using confocal imaging of anti-Lys6G6C, which indicates the extent of neutrophil and monocyte infiltration. Reparative mineralized bridge formation was assessed at 21 days post-procedure using high-resolution micro-computed tomography (micro-CT) and histology. Lastly, the homogeneity of the capping materials was evaluated by quantifying voids in calcium-silicate restorations using micro-CT. Results: DPC using TLC induced less infiltration of Lys6G6C+ cells at 24 h than BD or ES. BD promoted higher volumes of tertiary dentin than TLC, but TLC and ES showed no significant differences in volume. No differences were observed in material adaptation and void spaces among the three capping materials. Conclusions: All three materials under investigation supported pulp healing and maintained marginal integrity. However, TLC induced a lower inflammatory response on day 1 and induced similar levels of tertiary dentin to ES. These observations challenge the common perception that resin-based capping materials are not suitable for direct pulp capping. Our findings underscore the need to balance biological responses with physical properties when selecting pulp capping materials to improve long-term clinical success.

28 October 2025 in JBMR Plus
Verified
Journal Article
Open access
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
BDBella Donnelly
Bella Donnelly
JKJinju Kim
Jinju Kim
JSJack Sweet
Jack Sweet
FOFlavia Amadeu de Oliveira
Flavia Amadeu de Oliveira
BFBrian Foster
Brian Foster
X-linked hypophosphatemia (XLH) is caused by inactivating mutations in PHEX, leading to disturbed mineral metabolism, rickets, and osteomalacia. Dentoalveolar defects affecting dentin, cementum, and alveolar bone, contribute to dental abscesses and periodontal breakdown. Limited efficacy of current therapies for ameliorating XLH-associated dentoalveolar effects suggests mechanisms of disease that remain unchecked. Increased production and abnormal distribution of osteopontin (OPN) is thought to contribute to XLH-associated mineralization defects. Osteopontin is a secreted phosphoprotein and mineralization inhibitor, and a substrate of PHEX. To investigate the potential role of OPN in the pathology of XLH-associated dentoalveolar defects, a genetic approach was used to ablate or diminish Spp1/OPN in the Hyp mouse model of XLH. One or both Spp1 alleles in Hyp mice were deleted and tissues were analyzed at 60 d postnatally (dpn). Micro-CT showed no differences in volumes or densities of dentin and alveolar bone in Hyp mice lacking one or both Spp1 alleles, as compared to control Hyp mice. Histological assessment showed no improvements in cementum or periodontal ligament attachment, and dynamic mechanical analysis revealed no normalization of periodontal mechanical properties. While OPN may play a role in regulating dentoalveolar mineralization, diminishing OPN alone was not sufficient to substantially ameliorate XLH-associated defects.

26 January 2026 in Journal of Periodontology
Verified
Journal Article
Open access
KSKedith Sawangsri
Kedith Sawangsri
APAonjittra Phanrungsuwan
Aonjittra Phanrungsuwan
BLBinnaz Leblebicioglu
Binnaz Leblebicioglu
JMJose Luis Millan
Jose Luis Millan
BFBrian Foster
Brian Foster
Background: Alveolar bone loss challenges tooth retention and implant placement. Freeze‐dried bone allograft (FDBA) is widely used for alveolar ridge preservation but has limitations in resorption rate and healing time. In this proof‐of‐concept study, we tested whether pro‐mineralization enzyme, tissue‐nonspecific alkaline phosphatase (TNAP) enhances bone healing. Methods: Seven‐week‐old mice ( n = 4‐6/group; equal numbers of males and females) underwent maxillary molar extraction and standardized alveolar defect creation. Mice were assigned to sham, FDBA with saline (BGS) or FDBA with mineral‐targeted TNAP‐Fc‐D 10 (BGT). Healing was assessed using microcomputed tomography (micro‐CT), serum alkaline phosphatase (ALP) levels, histology, and immunohistochemistry, between 14‐ and 60‐days post‐procedure (dpp). Intergroup comparisons were analyzed by one‐way ANOVA and post‐hoc Tukey test ( α = 0.05) Results: At 14 dpp, the BGT group demonstrated significantly greater bone volume fraction (BV/TV) and bone mineral density (BMD) compared with BGS ( p < 0.01, p < 0.05) and sham groups ( p < 0.001). Alveolar bone volume was greater than sham ( p < 0.001). Alveolar bone dimension (height and width) was significantly more stable in the BGT group ( p < 0.05). Although BV/TV at 60 dpp showed no significant differences, BGT maintained higher BMD and alveolar bone width stability ( p < 0.01). Histological and immunohistochemical analyses revealed increased new bone formation and greater bone marker expression in the short‐term BGT group ( p < 0.05). No changes in serum ALP levels were detected. Conclusions: TNAP‐Fc‐D 10 with FDBA significantly enhances early alveolar bone healing and dimensional stability. While long‐term volumetric gains were not observed, sustained improvements in mineral density and ridge preservation support TNAP as a promising biologic for alveolar ridge preservation. Plain language summary: When people lose teeth, keeping enough bone in the jaw is critical for future treatments like dental implants. A common material used to rebuild bone is called freeze‐dried bone allograft (FDBA), but it does not always heal quickly or completely. In this study, we tested whether adding a special enzyme called TNAP, which helps build bones naturally, could make FDBA work better. After extracting teeth and creating bone defects in mice, we compared healing between three groups: control (sham), FDBA + saline, and FDBA + engineered TNAP‐Fc‐D 10 . After 2 weeks, the group that received FDBA+TNAP‐Fc‐D 10 showed more new bone formation and better preservation of the size of the jawbone. Even after 2 months, their bone remained denser and more stable compared with the other groups. Importantly, we found no signs of unwanted side effects in the blood. These results suggest that adding TNAP‐Fc‐D 10  could make bone grafts more effective early on, helping preserve jaw structure better over time. More research is needed to fine‐tune the treatment and see how well it works in humans.